Detalles de la búsqueda
1.
Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms.
Br J Haematol
; 202(2): 284-288, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37183377
2.
Cardiovascular calcifications in kidney transplant recipients.
Nephrol Dial Transplant
; 37(11): 2063-2071, 2022 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33620476
3.
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life study.
Br J Haematol
; 194(2): 336-343, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34151423
4.
The impact of functional delayed graft function in the modern era of kidney transplantation - A retrospective study.
Transpl Int
; 34(1): 175-184, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131120
5.
Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study.
Am J Transplant
; 20(11): 3030-3041, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32777153
6.
Kidney Graft Outcomes in High Immunological Risk Simultaneous Liver-Kidney Transplants.
Liver Transpl
; 26(4): 517-527, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32011089
7.
Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism.
Clin Transplant
; 34(8): e13988, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32438479
8.
A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
J Am Soc Nephrol
; 27(8): 2487-94, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26647424
9.
Taking care of kidney transplant recipients during the COVID-19 pandemic: Experience from a medicalized hotel.
Clin Transplant
; 35(1): e14132, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33103277
10.
An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI.
Transpl Int
; 29(3): 362-8, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26678359
11.
Clinical management of calcific uremic arteriolopathy before and after therapeutic inclusion of bisphosphonates.
Clin Nephrol
; 83(4): 231-4, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24075020
12.
Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study.
Nephrology (Carlton)
; 19(2): 84-93, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24428216
13.
The 'Phosphorus Week': involvement of Spanish nephrologists in the control of phosphorus blood levels.
Nefrologia (Engl Ed)
; 43(2): 232-238, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442711
14.
Transition of patients with metabolic bone disease from paediatric to adult healthcare services: current situation and proposals for improvement.
Orphanet J Rare Dis
; 18(1): 245, 2023 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37644568
15.
The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants.
Orphanet J Rare Dis
; 18(1): 8, 2023 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36624527
16.
Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM).
Nefrologia (Engl Ed)
; 43 Suppl 1: 1-36, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37202281
17.
Development of calciphylaxis in kidney transplant recipients with a functioning graft.
Clin Kidney J
; 15(4): 663-671, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35371461
18.
Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation.
Br J Haematol
; 172(5): 813-5, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26132594
19.
Panel Discussion: Some Aspects of the Management of Patients with X-Linked Hypophosphataemic Rickets.
Adv Ther
; 37(Suppl 2): 121-126, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236878
20.
Correction to: Panel Discussion: Some Aspects of the Management of Patients with X-Linked Hypophosphataemic Rickets.
Adv Ther
; 37(7): 3432, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32447651